These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 10998034)

  • 21. Evaluation of induction characteristics and hypnotic potency of isoflurane and sevoflurane in healthy dogs.
    Hofmeister EH; Brainard BM; Sams LM; Allman DA; Cruse AM
    Am J Vet Res; 2008 Apr; 69(4):451-6. PubMed ID: 18380575
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacodynamic, pharmacokinetic and clinical effects of clevidipine, an ultrashort-acting calcium antagonist for rapid blood pressure control.
    Nordlander M; Sjöquist PO; Ericsson H; Rydén L
    Cardiovasc Drug Rev; 2004; 22(3):227-50. PubMed ID: 15492770
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the effects of epidural or intravenous methadone on the minimum alveolar concentration of isoflurane in dogs.
    Campagnol D; Teixeira-Neto FJ; Peccinini RG; Oliveira FA; Alvaides RK; Medeiros LQ
    Vet J; 2012 Jun; 192(3):311-5. PubMed ID: 21962818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in minimal alveolar concentration of isoflurane following treatment with medetomidine and tiletamine/zolazepam, epidural morphine or systemic buprenorphine in pigs.
    Malavasi LM; Jensen-Waern M; Augustsson H; Nyman G
    Lab Anim; 2008 Jan; 42(1):62-70. PubMed ID: 18348767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isoflurane depresses diffuse noxious inhibitory controls in rats between 0.8 and 1.2 minimum alveolar anesthetic concentration.
    Jinks SL; Antognini JF; Carstens E
    Anesth Analg; 2003 Jul; 97(1):111-6, table of contents. PubMed ID: 12818952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of constant rate infusion of lidocaine and ketamine, with or without morphine, on isoflurane MAC in horses.
    Villalba M; Santiago I; Gomez de Segura IA
    Equine Vet J; 2011 Nov; 43(6):721-6. PubMed ID: 21668490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clevidipine: an ultra short-acting calcium channel antagonist for acute hypertension.
    Kenyon KW
    Ann Pharmacother; 2009 Jul; 43(7):1258-65. PubMed ID: 19584385
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of adenosine infusion on the minimum alveolar concentration of isoflurane in dogs.
    Asakawa M; Ludders JW; Badgley BL; Erb HN; Gleed RD; Posner LP
    Vet Anaesth Analg; 2007 Jan; 34(1):9-14. PubMed ID: 17238957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clevidipine for the treatment of severe hypertension in adults.
    Nguyen HM; Ma K; Pham DQ
    Clin Ther; 2010 Jan; 32(1):11-23. PubMed ID: 20171407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipophilic beta-adrenoceptor antagonist propranolol increases the hypnotic and anti-nociceptive effects of isoflurane in a swine model.
    Kurita T; Takata K; Morita K; Sato S
    Br J Anaesth; 2008 Jun; 100(6):841-5. PubMed ID: 18424803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetics and arteriovenous differences in clevidipine concentration following a short- and a long-term intravenous infusion in healthy volunteers.
    Ericsson H; Bredberg U; Eriksson U; Jolin-Mellgård A; Nordlander M; Regårdh CG
    Anesthesiology; 2000 Apr; 92(4):993-1001. PubMed ID: 10754618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In rats breathing from a nonrebreathing system, substitution of desflurane for isoflurane toward the end of anesthesia incompletely restores the time of recovery toward that of desflurane.
    Gong DH; Weiskopf RB; Neumann MA; Laster MJ; Eger EI
    Anesth Analg; 1998 Jan; 86(1):198-201. PubMed ID: 9428878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects on indicators of tissue perfusion in dogs anesthetized with isoflurane at two multiples of the minimum alveolar concentration.
    Floriano BP; Wagatsuma JT; Ferreira JZ; Abimussi CJ; Menegheti TM; Santos PS; Oliva VN
    Am J Vet Res; 2016 Jan; 77(1):24-31. PubMed ID: 26709933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of tramadol on minimum alveolar concentration (MAC) of isoflurane in rats.
    de Wolff MH; Leather HA; Wouters PF
    Br J Anaesth; 1999 Nov; 83(5):780-3. PubMed ID: 10690143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcium antagonist protects the myocardium from reperfusion injury by interfering with mechanisms directly related to reperfusion: an experimental study with the ultrashort-acting calcium antagonist clevidipine.
    Segawa D; Sjöquist PO; Wang QD; Gonon A; Nordlander M; Rydén L
    J Cardiovasc Pharmacol; 2000 Sep; 36(3):338-43. PubMed ID: 10975591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Isoflurane but not halothane minimum alveolar concentration-sparing response of dexmedetomidine is enhanced in rats chronically treated with selective α2-adrenoceptor agonist.
    Santos M; Ibancovichi JA; Millán I; Tendillo FJ
    Lab Anim; 2012 Jul; 46(3):215-9. PubMed ID: 22522415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuromuscular blocking effects of rocuronium during desflurane, isoflurane, and sevoflurane anaesthesia.
    Wulf H; Ledowski T; Linstedt U; Proppe D; Sitzlack D
    Can J Anaesth; 1998 Jun; 45(6):526-32. PubMed ID: 9669005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of 1- and 10-day administration of tepoxalin on minimum alveolar concentration of isoflurane and sevoflurane in dogs.
    Crist MA; Matthews NS; Oberle NL; Pappas C
    Vet Ther; 2007; 8(2):107-12. PubMed ID: 17616945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and pharmacokinetic results with a new ultrashort-acting calcium antagonist, clevidipine, following gradually increasing intravenous doses to healthy volunteers.
    Ericsson H; Fakt C; Jolin-Mellgård A; Nordlander M; Sohtell L; Sunzel M; Regårdh CG
    Br J Clin Pharmacol; 1999 May; 47(5):531-8. PubMed ID: 10336577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.